Continuous Biomolecule Manufacturing With Immiscible Phase Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current mRNA production processes are costly, require skilled personnel, generate hazardous waste, and lack flexibility in scaling up or down, making it difficult to produce small or large quantities efficiently and cost-effectively.
Innovation Solution
A continuous manufacturing system with a reaction chamber and immiscible phase control, using a monitoring and control unit to maintain consistent reaction conditions and separate phases, allowing scalable production of biomolecules from small to large quantities while preserving reaction quality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a continuous flow production system is used to produce large amounts of mRNA, then productivity is improved, but the system cannot be adapted to produce small quantities without wasting enzymes and buffers
Solution Approach 1:
The system dynamically adjusts the flow rates of reaction phase and immiscible phase based on the desired production quantity. The monitoring and control unit modifies injection parameters in real-time, allowing the same continuous flow system to adapt between small and large scale production without waste
Solution Approach 2:
The system changes operational parameters (flow rates, injection volumes, residence times) to optimize production for different scales. By adjusting these parameters, the system maintains efficiency whether producing thousands or millions of doses
2Adaptability or versatility
If batch mode production is used, then adaptability to different production scales is improved, but productivity and manufacturing efficiency deteriorate
Solution Approach 1:
The system maintains continuous operation with constant flow through the reaction chamber, eliminating the start-stop nature of batch processing. The immiscible phase continuously extracts mRNA while the reaction phase flows uninterrupted, maximizing productivity while maintaining scale flexibility through parameter adjustment
3Productivity
If a single continuous flow system is designed for large scale production, then productivity is improved, but device complexity increases to maintain consistent reaction conditions across varying scales
Solution Approach 1:
The monitoring and control unit continuously monitors production parameters and automatically adjusts flow rates and injection volumes to maintain optimal reaction conditions. This feedback mechanism simplifies operation by eliminating manual intervention while ensuring consistent quality across different production scales
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables flexible and efficient production of biomolecules, such as mRNA, by maintaining consistent reaction conditions and quality across varying scales, reducing waste and operational costs, and facilitating rapid adaptation to different production needs.
Implementation Method 1
a scale tank in fluid communication with the reaction chamber and suitable for storing an immiscible phase, which is not miscible with the reaction phase
Data Source
AI summary
A system for continuous manufacture of biomolecules includes feed tanks suitable for storing products and a reaction chamber designed to be fed with products from the feed tanks that form a reaction phase in the reaction chamber. The reaction chamber is designed to manufacture the biomolecules from the reaction phase. The system includes a scale tank in fluid communication with the reaction chamber, which is suitable for storing an immiscible phase, and a monitoring and control unit set to control the injection flow rate of the immiscible phase into the reaction chamber to keep constant a certain filling level of the reaction chamber according to the amount of reaction phase to be injected into the reaction chamber to manufacture a certain amount of biomolecules.